Bindra
Amrit P. Bindra, Brecksvile, OH US
Patent application number | Description | Published |
---|---|---|
20120095128 | Low VOC Colorants With Non Tip Drying - A colorant composition for tinting or coloring surface coverings or paint is. provided that has a low volatile organic compound (VOC) concentration, alkylphenoi ethoxylate surfactants (APE) free and hazardous air pollutants (HAPS) free. Additionally, the colorant composition has performance properties substantially equal to or better than tinters possessing high VOC concentrations. The colorant composition includes a colorant component, a dispersant including a polyamide, a surface active agent, water, and optional additives, The polyamide is a high molecular weight polyamide. having at least two anchoring amines, and the surface active agent includes phosphoric acid, phosphate esters, or salts thereof. | 04-19-2012 |
Dilbir S. Bindra, New Brunswick, NJ US
Patent application number | Description | Published |
---|---|---|
20080234366 | PHARMACEUTICAL FORMULATION CONTAINING AN SGLT2 INHIBITOR - Pharmaceutical formulations are provided which are in the form of capsules or tablets for oral use and which include a medicament dapagliflozin or its propylene glycol hydrate | 09-25-2008 |
20110064801 | Pharmaceutical Formulations Containing an SGLT2 Inhibitor - Pharmaceutical formulations are provided which are in the form of capsules or tablets for oral use and which include a medicament dapagliflozin or its propylene glycol hydrate | 03-17-2011 |
20120263786 | Pharmaceutical Formulations Containing an SGLT2 Inhibitor - Pharmaceutical formulations are provided which are in the form of capsules or tablets for oral use and which include a medicament dapagliflozin or its propylene glycol hydrate | 10-18-2012 |
20130039989 | PHARMACEUTICAL COMPOSITIONS COMPRISING N-(4-(2-AMINO-3-CHLOROPYRIDIN-4-YLOXY)-3-FLUOROPHENYL)-4-ETHOXY-1-(4-FLUO- ROPHENYL)-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXAMIDE - Disclosed are salts and crystalline forms of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide and salts thereof. Also disclosed are at least one pharmaceutical composition comprising at least one crystalline form of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide, at least one method of using at least one crystalline form of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide to treat cancer and/or other proliferative diseases, and processes to prepare crystalline forms of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide and salts thereof. | 02-14-2013 |
20130129819 | Pharmaceutical Formulations Containing An SGLT2 Inhibitor - Pharmaceutical formulations are provided which are in the form of capsules or tablets for oral use and which include a medicament dapagliflozin or its propylene glycol hydrate | 05-23-2013 |
20140243262 | PHARMACEUTICAL FORMULATIONS CONTAINING AN SGLT2 INHIBITOR - Pharmaceutical formulations are provided which are in the form of capsules or tablets for oral use and which include a medicament dapagliflozin or its propylene glycol hydrate | 08-28-2014 |
20150065719 | PHARMACEUTICAL COMPOSITIONS COMPRISING N-(4-(2-AMINO-3-CHLOROPYRIDIN-4-YLOXY)-3-FLUOROPHENYL)-4-ETHOXY-1-(4-FLUO- ROPHENYL)-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXAMIDE - Disclosed are salts and crystalline forms of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide and salts thereof. Also disclosed are at least one pharmaceutical composition comprising at least one crystalline form of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide, at least one method of using at least one crystalline form of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide to treat cancer and/or other proliferative diseases, and processes to prepare crystalline forms of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide and salts thereof. | 03-05-2015 |
Dilbir S. Bindra, Hillsborough, NJ US
Patent application number | Description | Published |
---|---|---|
20130296325 | HIGH DRUG LOAD TABLET FORMULATION OF [(1R), 2S]-2-AMINOPROPIONIC ACID 2-[4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-5-METHYLPYRROLO[2,1-f][1,2,4]TR- IAZIN-6-YLOXY]-1-METHYLETHYL ESTER - The present invention is directed to a high drug load tablet formulation of [(1R),2S]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester, and to methods of using the formulation in the treatment of cancer. The tablet is obtained by means of a wet granulation process. | 11-07-2013 |
20150119317 | ORAL SOLID DOSAGE FORMULATION OF 1,1-DIMETHYLETHYL [(1S)-1-CARBAMOYL)PYRROLIDIN-1-YL]CARBONYL}-2,2-DIMETHYLPROPYL]CARBAMATE - The present invention is directed to an oral solid dosage formulation of Asunaprevir, 1,1-dimethylethyl[(1S)-1-{[(2S,4R)-4-(7-chloro-4methoxyisoquinolin-1-yloxy)-2-({(1R,2S)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}carbamoyl)pyrrolidin-1-yl]carbonyl}-2,2-dimethylpropyl]carbamate, and to methods of using the formulation in the treatment and/or inhibition of the hepatitis C virus and infections caused thereby. | 04-30-2015 |
20150297603 | HIGH DRUG LOAD TABLET FORMULATION OF [(1R), 2S]-2-AMINOPROPIONIC ACID 2-[4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-5-METHYLPYRROLO[2,1-f][1,2,4]TR- IAZIN-6-YLOXY]-1-METHYLETHYL ESTER - The present invention is directed to a high drug load tablet formulation of [(1R), 2S]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester, and to methods of using the formulation in the treatment of cancer. | 10-22-2015 |
Dilpreet Bindra, Union City, CA US
Patent application number | Description | Published |
---|---|---|
20110145632 | TRANSPARENT RECOVERY FROM HARDWARE MEMORY ERRORS - A method is provided for recovering from an uncorrected memory error located at a memory address as identified by a memory device. A stored hash value for a memory page corresponding to the identified memory address is used to determine the correct data. Because the memory device specifies the location of the corrupted data, and the size of the window where the corruption occurred, the stored hash can be used to verify memory page reconstruction. With the known good part of the data in hand, the hashes of the pages using possible values in place of the corrupted data are calculated. It is expected that there will be a match between the previously stored hash and one of the computed hashes. As long as there is one and only one match, then that value, used in the place of the corrupted data, is the correct value. The corrupt data, once replaced, allows operation of the memory device to continue without needing to interrupt or otherwise affect a system's operation. | 06-16-2011 |
20110197090 | Error Reporting Through Observation Correlation - A software component is executed to carry out a task, the task including a subtask. An external function is called to perform the subtask, the external function executing in a separate thread or process. The component receives an observation recorded by the external function, the observation including an identifier of a possible error condition and instance data associated with the possible error condition. The possible error condition being a cause of the failure of the external function to carry out the subtask. If the task cannot be completed, then a new observation is recorded along with the received observation, the new observation being related to a possible error condition of the component, which is a cause of the failure of the component to carry out the task. When the task can be completed despite the failure of the external function, the observation recorded by the external function is cleared. | 08-11-2011 |
20130254612 | TRANSPARENT RECOVERY FROM HARDWARE MEMORY ERRORS - A method is provided for recovering from an uncorrected memory error located at a memory address as identified by a memory device. A stored hash value for a memory page corresponding to the identified memory address is used to determine the correct data. Because the memory device specifies the location of the corrupted data, and the size of the window where the corruption occurred, the stored hash can be used to verify memory page reconstruction. With the known good part of the data in hand, the hashes of the pages using possible values in place of the corrupted data are calculated. It is expected that there will be a match between the previously stored hash and one of the computed hashes. As long as there is one and only one match, then that value, used in the place of the corrupted data, is the correct value. The corrupt data, once replaced, allows operation of the memory device to continue without needing to interrupt or otherwise affect a system's operation. | 09-26-2013 |
Dilpreet S. Bindra, Hayward, CA US
Patent application number | Description | Published |
---|---|---|
20150082302 | HIGH AVAILABILITY USING DYNAMIC QUORUM-BASED ARBITRATION - Exemplary methods, apparatuses, and systems include a first virtual infrastructure manager (VIM) determining that the first VIM is to be an active manager of a plurality of virtual machines running on a plurality of host devices and that a second VIM is to be a standby manager of the plurality of virtual machines. The first VIM selects a first host device from the plurality of host devices to serve as a passive witness node in arbitrating active and standby roles between the first VIM and second VIM. The first host device runs one or more virtual machines and is managed by the active manager. The first VIM selects a first host device by confirming that the first host device is available to each of the first VIM and the second VIM. The first VIM writes a file on the first host device indicating that the first VIM is the active manager. | 03-19-2015 |
Gagan Bindra, Bhopal IN
Patent application number | Description | Published |
---|---|---|
20100104063 | METHOD AND SYSTEM FOR AUTO POSITIONING COMPRESSION MECHANISM IN A MAMMOGRAPHY SYSTEM - A method and system for auto positioning a compression mechanism in a mammography imaging system is disclosed herewith. The method comprises: automatically elevating the compression mechanism upon detection of a breast biopsy device. The breast biopsy device can be detected upon connecting the same to the mammography system or can be detected upon noticing the same on the vicinity of the mammography system. The compression mechanism includes: breast compressor, breast holding paddles and paddle holders. | 04-29-2010 |
Gurbrinder Singh Bindra, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20130005414 | MULTI-PURPOSE INTELLIGENT CRADLE FOR A VEHICLE - The present invention provides a mobile device cradle for a vehicle. The cradle may include docking members for receiving a mobile device of a driver of the vehicle. The cradle may also include a face recognition means for periodically capturing a face of the driver, environmental conditions, and traffic conditions. Further, the cradle may include an authentication unit for authenticating the mobile device and the face of the driver captured by the face recognition means and for providing an authentication signal for starting the vehicle to an electronic engine control unit (EECU). Furthermore, the cradle may include an information collection unit for collecting dynamic information associated with the driver and the vehicle from monitoring units. Moreover, the cradle may also include a communication unit for communicating the dynamic information to back office system(s) communicatively coupled to the mobile device via a wireless communication network. | 01-03-2013 |
20130144811 | SYSTEM AND METHOD FOR COMPUTING A VARIABLE FUEL PRICE BASED ON EXHAUST GAS EMISSIONS OF A VEHICLE - The present invention provides a system and method of computing a variable fuel price based on exhaust gas emission of a vehicle. In one embodiment, a system includes an onboard unit fitted in a vehicle for measuring amount of exhaust gas emissions by the vehicle and a remote server communicatively connected to the onboard unit for computing a discount or surcharge on a base fuel price based on the amount of exhaust gas emissions by the vehicle. The system also includes a fuel station communicatively coupled to the remote server for filling fuel in a fuel tank of the vehicle at the discounted or surcharge fuel price. | 06-06-2013 |
Gurmeet Singh Bindra, Dublin IE
Patent application number | Description | Published |
---|---|---|
20160087295 | Catalyst and Process for the Production of Hydrogen from Ammonia Boranes - The present invention relates to a process for the production of hydrogen comprising contacting at least one complex of formula (I), (I) wherein: X | 03-24-2016 |
Hitesh Bindra, New York, NY US
Patent application number | Description | Published |
---|---|---|
20140202157 | THERMAL ENERGY STORAGE FOR COMBINED CYCLE POWER PLANTS - Thermal storage systems that preferably do not create substantially any additional back pressure or create minimal additional back pressure and their applications in combined cycle power plants are disclosed. In one embodiment of the method for efficient response to load variations in a combined cycle power plant, the method includes providing, through a thermal storage tank, a flow path for fluid exiting a gas turbine, placing in the flow path a storage medium comprising high thermal conductivity heat resistance media, preferably particles, the particles being in contact with each other and defining voids between the particles in order to facilitate flow of the fluid in a predetermined direction constituting a longitudinal direction, arrangement of the particles constituting a packed bed, dimensions of the particles and of the packed bed being selected such that a resultant back pressure to the gas turbine is at most a predetermined back pressure. | 07-24-2014 |
Hitesh Bindra, Fort Lee, NJ US
Patent application number | Description | Published |
---|---|---|
20140299306 | OPTIMUM PROCESS DESIGN OF PACKED BED TYPE THERMAL STORAGE SYSTEMS AND OTHER APPLICATIONS - Methods and systems for optimizing the process of heat and/or mass transfer operations in packed beds and embodiments of applications of the methods are disclosed herein below. In one instance, the method results in the profile of the quantity representative of the heat and/or mass transfer operation having a propagating substantially sharp front. | 10-09-2014 |
Mandeep Bindra, Somerset, NJ US
Patent application number | Description | Published |
---|---|---|
20130122072 | DELIVERY SYSTEM FOR ACTIVE COMPONENTS AS PART OF AN EDIBLE COMPOSITION - A delivery system for inclusion in an edible composition is formulated to have at least one active component with an encapsulating material for delivering the active component upon consumption of the edible composition wherein the dispersion of active component particles, as measured by the average distance between active component particles in the delivery system divided by the average particle diameter of the active component particles, is from 0.5 to 20. | 05-16-2013 |
Mandeep Bindra, Whippany, NJ US
Patent application number | Description | Published |
---|---|---|
20150118352 | SYSTEM AND METHOD FOR MANUFACTURING CHEWING GUM - Disclosed is a method for manufacturing chewing gum, the method including feeding one or more gum ingredients including at least an elastomer into a continuous extruder including a plurality of screws, rotating screws and mixing the one or more ingredients via the rotating of the screws within the continuous extruder, forming a partial chewing gum base via the mixing of the one or more ingredients, creating a flow of the partial chewing gum base including the one or more ingredients through the continuous extruder towards a downstream extent of the plurality of screws via the rotating, and conveying the flow of the partial chewing gum base to a region of the continuous extruder that is proximate the downstream extent of the plurality of screws, wherein the flow includes a temperature of less than 90 degrees Celsius when the flow reaches the downstream extent of the plurality of screws. Some independent claims relate to a flow reaching two different temperatures that are within 20 degrees Celsius. Some independent claims relate to systems comprising extruders having at least three screws. Some independent claims relate to methods for making chewing gums comprising among others the step of feeding an elastomer into a planetary roller extruder. | 04-30-2015 |
Manjit Singh Bindra, Mysore IN
Patent application number | Description | Published |
---|---|---|
20100294828 | RECOGNITION OF INTERCHANGEABLE COMPONENT OF A DEVICE - A device and a method are provided for determining a characteristic of an interchangeable component of a surgical instrument. An electrically conductive material having a measurable strength measurable by a hall effect sensor is coupled to the component. In another embodiment, a plurality of conductive materials are arranged to form a binary code representing a corresponding of the interchangeable component. The number and/or strength of the magnets measurable by the sensors may be dynamically altered such that the status of the surgical instrument is determinable. | 11-25-2010 |
20110082474 | WIRELESS CLIP COUNTER - An apparatus for application of surgical clips to body tissue is provided and includes a housing, at least one handle pivotably connected to the housing, a channel assembly extending distally from the housing, a clip carrier disposed within the channel assembly and defining a channel and a plurality of windows therein, and a plurality of clips slidably disposed within the channel of the clip carrier. The apparatus also includes a counter mechanism supported in at least one of the housing and the channel assembly. The counter mechanism is configured to transmit a change in status of the apparatus upon each actuation of the at least one handle. | 04-07-2011 |
Perminder S. Bindra, Fripp Island, SC US
Patent application number | Description | Published |
---|---|---|
20080308776 | CHEMILUMINESCENT COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF - Described herein are chemiluminescent compositions that can be applied to a variety of substrates that are generally sensitive to existing chemiluminescent compositions. Methods for producing the chemiluminescent compositions are also provided. | 12-18-2008 |
20100288984 | CHEMILUMINESCENT POWDERS AND METHODS OF MAKING AND USING THEREOF - Described herein are chemiluminescent powders that can be applied to a variety of substrates that are generally sensitive to existing chemiluminescent compositions. Methods for producing the chemiluminescent compositions are also provided. | 11-18-2010 |
20110284811 | CHEMILUMINESCENT POWDERS AND METHODS OF MAKING AND USING THEREOF - Described herein are chemiluminescent powders that can be applied to a variety of substrates or incorporated into a variety of articles that are generally sensitive to existing chemiluminescent compositions. Methods for producing the chemiluminescent compositions are also provided. | 11-24-2011 |
Randip R. Bindra, Clarendon Hills, IL US
Patent application number | Description | Published |
---|---|---|
20120226296 | SURGICAL DEVICE FOR SOFT TISSUE REPAIR AND SURGICAL KIT INCLUDING SUCH A DEVICE - The device ( | 09-06-2012 |
20140074247 | JOINT RECONSTRUCTION SYSTEM AND METHOD - The implant ( | 03-13-2014 |
Ranjit Bindra, New York, NY US
Patent application number | Description | Published |
---|---|---|
20100172882 | COMPOSITIONS AND METHODS FOR TARGETED INACTIVATION OF HIV CELL SURFACE RECEPTORS - Compositions for targeted mutagenesis of cell surface receptors for HIV and methods of their use are provided herein. The compositions include triplex-forming molecules that bind to duplex DNA in a sequence specific manner at target sites to form triple-stranded structures. The triplex-forming molecules can be triplex-forming oligonucleotides (TFOs) or peptide nucleic acids (PNAs). The triplex-forming molecules are useful to induce site-specific homologous recombination in mammalian cells when used in combination with donor oligonucleotides. The triplex-forming molecules target sites within or adjacent to genes that encodes cell surface receptors for human immunodeficiency virus (HIV). This binding stimulates homologous recombination of a donor oligonucleotide to cause mutations in HIV cell surface receptor genes that result in one or more deficiencies in the ability of the encoded receptor to bind to HIV and allow its transport into the cell. Methods for ex vivo and in vivo prophylaxis and therapy of HIV infection using the disclosed compositions are also provided. | 07-08-2010 |
Ranjit S. Bindra, New York, NY US
Patent application number | Description | Published |
---|---|---|
20110262406 | COMPOSITIONS AND METHODS FOR TARGETED INACTIVATION OF HIV CELL SURFACE RECEPTORS - Compositions for targeted mutagenesis of cell surface receptors for HIV and methods of their use are provided herein. The compositions include triplex-forming molecules that displace the polypyrimidine strand of target duplex and form a triple-stranded structure and hybrid duplex in a sequence specific manner with the polypurine strand of the target duplex. The triplex-forming molecules include a mixed-sequence “tail” which increases the stringency of binding to the target duplex, improves the frequency of modification at the target site, and reduces the requirement for a polypurine:polypyrimidine stretch. Methods for using the triplex-forming molecules in combination with one or more donor oligonucleotides for targeted modification of sites within or adjacent to genes that encodes cell surface receptors for human immunodeficiency virus (HIV) are also disclosed. Methods for ex vivo and in vivo prophylaxis and therapy of HIV infection using the disclosed compositions are also provided. | 10-27-2011 |
20110293585 | COMPOSITIONS AND METHODS FOR TREATMENT OF LYSOSOMAL STORAGE DISORDERS - Compositions and methods for treating lysosomal storage diseases are disclosed. Lysosomal dysfunction is usually the result of deficiency of a single enzyme necessary for the metabolism of lipids, glycoproteins (sugar containing proteins) or mucopolysaccharides which are fated for breakdown or recycling. The compositions contain triplex-forming molecules which can be used to induce site-specific homologous recombination in mammalian cells when combined with donor DNA molecules, by stimulating cellular DNA synthesis, recombination, and repair mechanisms. The methods are particular useful for correcting point mutations in genes associated with lysosomal storage diseases such as Gaucher's disease, Fabry disease, and Hurler syndrome. Methods for determining the frequency of target gene repair and assessing the restoration of the enzymatic activity of corrected polypeptides are also disclosed. Ex vivo and in vivo methods of gene correction in patients are also provided. | 12-01-2011 |
Sarvjeet S. Bindra, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20100067974 | Binder for holding materials - A lightweight binder for securing papers, the binder being constructed from a polyfoam material and having a closure to secure the binder panels and paper together, a mesh pocket also being provided with a closure for storing items therein. The polyfoam layer may be laminated with other layers which form the a binder surfaces. | 03-18-2010 |
Vikram Bindra, Panipat IN
Patent application number | Description | Published |
---|---|---|
20160113908 | Transdermal Therapeutic System for Extended Dosing of Pramipexole in Treating Neurological Disorders - This disclosure relates to a transdermal therapeutic system (TTS) containing pramipexole or related compounds and methods of making the system as well as its use in administering such compounds as a single dose over an extended period, for example, one week. The system comprises an acrylic-based or silicone-based matrix layer containing pramipexole at concentrations of at least about 5 wt. % of the matrix, which is resistant to crystallizing and discoloration of the active ingredient even when stored over long periods. | 04-28-2016 |